Welcome to Pharmalix
About Pharmalix
Pharmalix is an EU-based OTC development project focused on export-oriented, high-demand over-the-counter products. The project is currently in the development and feasibility phase and operates with a clear B2B focus.
Pharmalix does not operate its own manufacturing facilities. All products are planned to be manufactured via EU-GMP certified contract manufacturers.
Project Focus
Pharmalix focuses on:
• Export-oriented OTC products
• High-demand, non-branded formulations
• Batch-based production models
• Long shelf-life products
• Flexible, market-specific packaging
Initial product focus:
• Electrolyte Powder (ORS-type)
Manufacturing Model
Pharmalix follows a contract manufacturing model:
• EU-GMP compliant manufacturing partners
• Neutral or bulk packaging
• Market-specific secondary packaging
• Quality control and batch release according to EU standards
This approach allows efficient scaling while maintaining regulatory and quality compliance.
Markets & Distribution
Pharmalix is focused on B2B distribution for:
• EU wholesalers and distributors
• Export-oriented OTC portfolios
• Private-label and neutral supply models
Pharmalix does not engage in direct-to-consumer sales and does not operate an in-country sales force.
Project Status
Pharmalix is currently in the partner evaluation and feasibility stage, including:
• Contract manufacturer evaluation
• Cost and batch feasibility analysis
• Distributor and portfolio alignment discussions
No commercial production has started at this stage.
Contact
Pharmalix – OTC Project Entity
Hamburg, Germany
Email: hamidi@pharmalix.eu